For 2004, the Guide contains an expanded series of company summaries, a ranking table for the WoodMac 50 and an in-depth analysis of opportunities and critical issues for the pharmaceutical and biotechnology industries.
The 2004 edition includes:
-Five for '05: Our top five issues and trends that life sciences companies will face in the coming year
-Concise executive summaries for each of the WoodMac 50
-Wood Mackenzie's Freshness Index, which measures the health of pipelines based on portfolio maturity
-Company rankings for the WoodMac 50
-In-depth analysis of key therapeutic areas, companies and products in 2003